Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters

The biosimilar concept is now well established. Clinical data accumulated pre- and post-approval have supported biosimilar uptake, in turn stimulating competition in the biologics market and increasing patient access to biologics. Following technological advances, other innovative biologics, such as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Kim, HoUng, Alten, Rieke, Cummings, Fraser, Danese, Silvio, D’Haens, Geert, Emery, Paul, Ghosh, Subrata, Gilletta de Saint Joseph, Cyrielle, Lee, JongHyuk, Lindsay, James O., Nikiphorou, Elena, Parker, Ben, Schreiber, Stefan, Simoens, Steven, Westhovens, Rene, Jeong, Ji Hoon, Peyrin-Biroulet, Laurent
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889098/
https://ncbi.nlm.nih.gov/pubmed/33557682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2020.1868078
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados